Cargando…

Melatonin as a potential inhibitory agent in head and neck cancer

Melatonin is a molecule secreted by the pineal gland; it is an important regulator of sleep and circadian rhythms. Through multiple interrelated mechanisms, melatonin exhibits various inhibitory properties at different stages of tumor progression. Many studies have explored the oncostatic effects of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Chia-Ming, Su, Shih-Chi, Lin, Chiao-Wen, Yang, Wei-En, Chien, Ming-Hsien, Reiter, Russel J., Yang, Shun-Fa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685773/ https://www.ncbi.nlm.nih.gov/pubmed/29163852 http://dx.doi.org/10.18632/oncotarget.20079

Ejemplares similares

Melatonin inhibits TPA-induced oral cancer cell migration by suppressing matrix metalloproteinase-9 activation through the histone acetylation
por: Yeh, Chia-Ming, et al.
Publicado: (2016)

Molecular and Cellular Mechanisms of Melatonin in Osteosarcoma
por: Lu, Ko-Hsiu, et al.
Publicado: (2019)

Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2017)

Effects of miR-34b/miR-892a Upregulation and Inhibition of ABCB1/ABCB4 on Melatonin-Induced Apoptosis in VCR-Resistant Oral Cancer Cells
por: Hsieh, Ming-Ju, et al.
Publicado: (2020)

Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
por: Reiter, Russel J., et al.
Publicado: (2017)

Melatonin as a Potential Agent in the Treatment of Sarcopenia
por: Coto-Montes, Ana, et al.
Publicado: (2016)

Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies
por: Egea, Javier, et al.
Publicado: (2022)

New markers in pneumonia
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Dual Targeting of the p38 MAPK-HO-1 Axis and cIAP1/XIAP by Demethoxycurcumin Triggers Caspase-Mediated Apoptotic Cell Death in Oral Squamous Cell Carcinoma Cells
por: Chien, Ming-Hsien, et al.
Publicado: (2020)

Interactions between Environmental Factors and Melatonin Receptor Type 1A Polymorphism in Relation to Oral Cancer Susceptibility and Clinicopathologic Development
por: Lin, Feng-Yan, et al.
Publicado: (2015)

Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
por: Loh, Doris, et al.
Publicado: (2021)

The Multiple Functions of Melatonin: Applications in the Military Setting
por: Gancitano, Giuseppe, et al.
Publicado: (2022)

Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chung, Tsung-Te, et al.
Publicado: (2012)

Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review
por: Fernández-Palanca, Paula, et al.
Publicado: (2021)

Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma
por: Lin, Yung-Wei, et al.
Publicado: (2017)

Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia
por: Loh, Doris, et al.
Publicado: (2023)

Clinical Uses of Melatonin in Pediatrics
por: Sánchez-Barceló, Emilio J., et al.
Publicado: (2011)

Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers
por: Hsieh, Pei-Ling, et al.
Publicado: (2022)

Melatonin improves muscle injury and differentiation by increasing Pax7 expression
por: Su, Chen-Ming, et al.
Publicado: (2023)

Melatonin reduces lipid peroxidation and membrane viscosity
por: Reiter, Russel J., et al.
Publicado: (2014)

Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
por: Loh, Doris, et al.
Publicado: (2022)

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
por: Simko, Fedor, et al.
Publicado: (2020)

Neurotoxins: Free Radical Mechanisms and Melatonin Protection
por: Reiter, Russel J., et al.
Publicado: (2010)

Quercetin suppresses cellular migration and invasion in human head and neck squamous cell carcinoma (HNSCC)
por: Chan, Chien-Yi, et al.
Publicado: (2016)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
por: Shukla, Mayuri, et al.
Publicado: (2017)

Melatonin and Carbohydrate Metabolism in Plant Cells
por: Arnao, Marino B., et al.
Publicado: (2021)

Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
por: Loh, Doris, et al.
Publicado: (2022)

IGF2BP2 Polymorphisms Are Associated with Clinical Characteristics and Development of Oral Cancer
por: Chou, Chia-Hsuan, et al.
Publicado: (2020)

Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration
por: Blasiak, Janusz, et al.
Publicado: (2016)

Melatonin: A Versatile Protector against Oxidative DNA Damage
por: Galano, Annia, et al.
Publicado: (2018)

Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018)

Melatonin Synthesis and Function: Evolutionary History in Animals and Plants
por: Zhao, Dake, et al.
Publicado: (2019)

Cardioprotective Role of Melatonin in Acute Myocardial Infarction
por: Fu, Zhenhong, et al.
Publicado: (2020)

Use of Melatonin in Oxidative Stress Related Neonatal Diseases
por: D’Angelo, Gabriella, et al.
Publicado: (2020)

Melatonin is a potential inhibitor of ovarian cancer: molecular aspects
por: Zare, Hadis, et al.
Publicado: (2019)

Melatonin and cancer suppression: insights into its effects on DNA methylation
por: Davoodvandi, Amirhossein, et al.
Publicado: (2022)

Clinical Significance of Frailty on Treatment Outcome in Nongeriatric Patients With Head and Neck Cancer and Esophageal Cancer Undergoing Curative-Intent Concurrent Chemoradiotherapy
por: Chou, Wen-Chi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_90gru0nqhk8mmt1sn8mik354g9